Skip to content

Ultrasound-based Breast Cancer Screening in Chinese Women

Ultrasound-based Breast Cancer Screening in Chinese Women

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02268643
Enrollment
20000
Registered
2014-10-20
Start date
2014-01-31
Completion date
2017-12-31
Last updated
2014-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, screening, ultrasound, risk model

Brief summary

In the present study, the investigators will screen breast cancer of the Chinese women based on ultrasound and aim to compare the risk evaluation model of PUMCH model which was established by our previous work with other risk models.

Detailed description

Early detection of breast cancer through screening has been a common practice in the United States and several European countries for decades. It is effective in reducing the mortality of breast cancer and improving the postoperative quality of life of patients. Mammography has been the standard imaging method for the screening, however, our previous study has shown that ultrasound is more sensitive and less expensive than mammography. In the present study, the investigators will screen breast cancer of the Chinese women based on ultrasound and aim to evaluate the risk model (PUMCH model) which was established by our previous work.

Interventions

OTHERultrasound plus clinical breast examination

all the participants will be required to fill risk factor questionaires and then be screened with ultrasound plus physical examination every year

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Written informed consent; * residence from community or working units

Exclusion criteria

* pregnancy; * lactation; * known metastatic cancer; * signs or symptoms of breast disease; * presence of breast implants, breast surgery within prior 12 months; * had mammography or ultrasound exam within prior 12 months * males.

Design outcomes

Primary

MeasureTime frame
number of cancer detected in the high-risk group3 years

Countries

China

Contacts

Primary ContactSun Qiang, MD
sunqiangpumc@163.com86-010-69152701
Backup ContactShen Songjie, MD
pumcssj@163.com86-010-69152701

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026